Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Business sectors
- pharmaceutical industry [1]
- Company / filing name
- Emergent BioSolutions Inc. [2]
- Headquarters location
- Gaithersburg [1]
- Founded
- 1998; 2003-12-19 [1]
- Legal form
- Delaware corporation [1]
- Founders
- Fuad El-Hibri [1]
- Official website
- http://www.emergentbiosolutions.com; http://emergentbiosolutions.com/ [1]
- ISIN (reported securities)
- US29089Q1058 [1]
- CIK
- 1367644 [2]
- Country in background record
- United States [1]
- Symbols / exchanges
- EBS (NYSE) [2]
Company positioning and business
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. [3]
Among the company's products are the controversial BioThrax (Anthrax Vaccine Adsorbed), the only anthrax vaccine licensed by the U.S. Food and Drug Administration (FDA) and Narcan (naloxone) for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid. [3]
During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. [3]
Background text: Wikipedia contributors, Emergent BioSolutions. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Financial year, securities and disclosures
Listed securities: EBS (NYSE). Multiple symbols may represent different share classes or securities of the same registrant. [2]
Financial results and regulatory disclosures
No individual financial documents have been indexed yet. Open the source to consult company disclosures. [2]
Related entities and concepts
Frequently asked questions
When was Emergent BioSolutions Inc. founded?
Founded: 1998; 2003-12-19. The linked source provides the background record. [1]
Where is the headquarters of Emergent BioSolutions Inc.?
Headquarters location: Gaithersburg. The linked source provides the background record. [1]
Which business sectors are recorded for Emergent BioSolutions Inc.?
Business sectors: pharmaceutical industry. The linked source provides the background record. [1]
Sources and review dates
- Wikidata — company background record (CC0) ↗
- Company identity and profile data ↗
- Wikipedia contributors — Emergent BioSolutions (CC BY-SA 4.0) ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.